WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...
Moderna held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology. By Christina Jewett and ...
Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...
Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s MRNA3.60%increase; green up pointing triangle application to sell a new seasonal flu shot after the vaccine ...
The FDA will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of-its-kind shot. Moderna announced the ...
Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
The Food and Drug Administration agreed Wednesday to review Moderna’s application to make a new seasonal flu shot available, after initially refusing to do so. The back-and-forth reveals increased ...
The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...
The US Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday. About two weeks ago, the FDA sent Moderna a ...
The Food and Drug Administration will review Moderna’s new flu vaccine after initially refusing to review the candidate, the Cambridge biotech announced early Wednesday. The FDA’s decision not to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results